止血器
止血剂
止血
生物医学工程
生物相容性
体内
粘附
密封剂
止血剂
化学
材料科学
外科
医学
复合材料
冶金
生物技术
生物
作者
Sevana Baghdasarian,Bahram Saleh,Avijit Baidya,Han‐Jun Kim,Mahsa Ghovvati,Ehsan Shirzaei Sani,Reihaneh Haghniaz,Shashank Madhu,Maria Kanelli,Iman Noshadi,Nasim Annabi
标识
DOI:10.1016/j.mtbio.2021.100199
摘要
Controlling bleeding from a raptured tissue, especially during the surgeries, is essentially important. Particularly for soft and dynamic internal organs where use of sutures, staples, or wires is limited, treatments with hemostatic adhesives have proven to be beneficial. However, major drawbacks with clinically used hemostats include lack of adhesion to wet tissue and poor mechanics. In view of these, herein, we engineered a double-crosslinked sealant which showed excellent hemostasis (comparable to existing commercial hemostat) without compromising its wet tissue adhesion. Mechanistically, the engineered hydrogel controlled the bleeding through its wound-sealing capability and inherent chemical activity. This mussel-inspired hemostatic adhesive hydrogel, named gelatin methacryloyl-catechol (GelMAC), contained covalently functionalized catechol and methacrylate moieties and showed excellent biocompatibility both in vitro and in vivo. Hemostatic property of GelMAC hydrogel was initially demonstrated with an in vitro blood clotting assay, which showed significantly reduced clotting time compared to the clinically used hemostat, Surgicel®. This was further assessed with an in vivo liver bleeding test in rats where GelMAC hydrogel closed the incision rapidly and initiated blood coagulation even faster than Surgicel®. The engineered GelMAC hydrogel-based seaalant with excellent hemostatic property and tissue adhesion can be utilized for controlling bleeding and sealing of soft internal organs.
科研通智能强力驱动
Strongly Powered by AbleSci AI